Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECIGEN, INC. Director's Dealing 2021

Oct 20, 2021

32044_dirs_2021-10-20_eeaa5cab-7db0-4c46-99db-ff6826df2039.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECIGEN, INC. (PGEN)
CIK: 0001356090
Period of Report: 2021-10-18

Reporting Person: Thomasian Harry Jr. (Chief Financial Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-10-18 Option to Purchase Common Stock (Right to Buy) $4.72 A 180000 Acquired 2031-10-18 Common Stock (180000) Direct

Footnotes

F1: The option vests in four equal installments on each of October 18, 2022, October 18, 2023, October 18, 2024 and October 18, 2025.